Filter results by: Taxon Proteome
1 - 50 of 4059 UniProtKB matches
(5371 models, 5008 structures.)
UniProtKB AC
(Name)
UniProtKB Section
 
Homology Model
 
Experimental Structure
OrganismDescription
P9WJU7
(MMPL7_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Phthiocerol dimycocerosate exporter MmpL7;
Q79FU3
(PG16_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
PE-PGRS family protein PE_PGRS16;
P9WKW1
(Y476_MYCTU)
Swiss-ProtMycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Uncharacterized protein Rv0476;
P9WJ51
(VPB13_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Putative antitoxin VapB13;
P9WKP5
(Y898_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Uncharacterized protein Rv0898c;
O33348
(RELG_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Toxin RelG;
Putative endoribonuclease RelG;
O86365
(Y584_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Uncharacterized glycosidase Rv0584;
P9WMR3
(DNAB_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Replicative DNA helicase DnaB;
DNA 5'-3' helicase DnaB;
Endonuclease PI-MtuHIP;
3.1.-.-;
Mtu DnaB intein;
P95006
(VPB19_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Putative antitoxin VapB19;
P9WN17
(Y3198_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Putative glutaredoxin Rv3198A;
P9WQF1
(MBTL_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Acyl carrier protein MbtL;
Mycobactin synthase protein L;
P71905
(RNE_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Ribonuclease E;
O06777
(VAPB7_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Putative antitoxin VapB7;
P9WF43
(WHIB1_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Transcriptional regulator WhiB1;
O69622
(API1_MYCTU)
Swiss-ProtMycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Apoptosis inhibitor Rv3654c;
P9WJ27
(VPB37_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Putative antitoxin VapB37;
P9WJ35
(VPB30_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Antitoxin VapB30;
P9WJT9
(MMPLB_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Heme uptake protein MmpL11;
P9WQK7
(UVRA_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
UvrABC system protein A;
Excinuclease ABC subunit A;
P9WLJ7
(Y2087_MYCTU)
Swiss-ProtMycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Uncharacterized protein Rv2087;
P9WKY5
(HAT_MYCTU)
Swiss-ProtMycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Histone acetyltransferase;
P0CL61
(MAZE9_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Antitoxin MazE9;
P9WFV3
(SYI_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Isoleucine--tRNA ligase;
Isoleucyl-tRNA synthetase;
P9WIQ5
(RECC_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
RecBCD enzyme subunit RecC;
Exonuclease V subunit RecC;
Helicase/nuclease RecBCD subunit RecC;
P9WNL7
(EMBB_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Probable arabinosyltransferase B;
P9WNT5
(DNAE2_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Error-prone DNA polymerase;
P71622
(VPB22_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Antitoxin VapB22;
P9WJ75
(PARD2_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Antitoxin ParD2;
O53778
(VPB26_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Antitoxin VapB26;
P95262
(VPB14_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Putative antitoxin VapB14;
P9WIP5
(MBTH_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Protein MbtH;
Q6MX43
(DODEC_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Calcium dodecin;
P9WPQ1
(BTB7_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Biotinylated protein TB7.3;
P9WMQ3
(RECB_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
RecBCD enzyme subunit RecB;
DNA 3'-5' helicase subunit RecB;
Exonuclease V subunit RecB;
Helicase/nuclease RecBCD subunit RecB;
P9WFU7
(LYSX_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Lysylphosphatidylglycerol biosynthesis bifunctional protein LysX;
Lysine--tRNA ligase;
6.1.1.6;
Lysyl-tRNA synthetase;
LysRS;
Phosphatidylglycerol lysyltransferase;
2.3.2.3;
Lysylphosphatidylglycerol synthetase;
LPG synthetase;
V5QPS4
(3098B_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Putative antitoxin Rv3098B/RVBD_3098B;
Q50631
(CAR_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Carboxylic acid reductase;
ATP/NADPH-dependent carboxylic acid reductase;
FAAL9;
Medium/long-chain-fatty-acid--AMP ligase FadD9;
P9WJ25
(VPB38_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Putative antitoxin VapB38;
P9WJ45
(VPB20_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Antitoxin VapB20;
P9WKK3
(IF1_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Translation initiation factor IF-1;
O07227
(VAPB2_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Antitoxin VapB2;
P9WJ55
(VAPB9_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Putative antitoxin VapB9;
O06342
(Y3479_MYCTU)
Swiss-ProtMycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Uncharacterized membrane protein Rv3479;
P9WJU5
(MMPL8_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Sulfolipid-1 exporter MmpL8;
P9WJT7
(MMPLC_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Probable transport protein MmpL12;
P9WP75
(CSPA_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Probable cold shock protein A;
P71820
(FERX_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Ferredoxin Fdx;
P9WJ31
(VPB34_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Putative antitoxin VapB34;
P9WPK3
(CARB_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Carbamoyl phosphate synthase large chain;
Carbamoyl phosphate synthetase ammonia chain;
P9WI65
(PKNK_MYCTU)
Swiss-Prot
Mycobacterium tuberculosis
(strain ATCC 25618 / H37Rv)
Serine/threonine-protein kinase PknK;
Protein kinase K;
1 - 50 of 4059
Mycobacterium tuberculosis (ATCC 25618 / H37Rv)

Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) is an obligate pathogenic bacterial species in the family Mycobacteriaceae and the causative agent of tuberculosis (TB). First discovered in 1882 by Robert Koch, M. tuberculosis has an unusual, waxy coating on its cell surface (primarily due to the presence of mycolic acid), which makes the cells impervious to Gram staining. The physiology of M. tuberculosis is highly aerobic and requires high levels of oxygen. It is primarily a pathogen of the mammalian respiratory system and mainly infects the lungs.

An estimated one third of the world population is infected with M. tuberculosis (around 90% in a latent state). TB was responsible for 1.5 million deaths in 2014, with 9.6 million acute cases. TB is considered a leading cause of death worldwide alongside HIV.

The genome of M. tuberculosis was first sequenced in 1998.

"2015 Global tuberculosis report", World Health Organization

"Mycobacterium tuberculosis", Wikipedia: The Free Encyclopedia

Protein models in Repository

From left to right: i) The number of proteins in the reference proteome of Mycobacterium tuberculosis, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Mycobacterium tuberculosis for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.

For information on the latest proteome for Mycobacterium tuberculosis, please visit UniProtKB.

You can easily download the latest protein sequences for Mycobacterium tuberculosis proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2026_02 that was used for the most up to date SWISS-MODEL Repository.

Proteins in proteomeSequences modelledModels
3,9973,3475,361

Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.

Structural Coverage

The plot shows the evolution over years (x-axis) of the fraction of Mycobacterium tuberculosis reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.

Residue Coverage

This chart shows the percentage of residues in the Mycobacterium tuberculosis proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.

Oligomeric State

Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.

Single Chain2-mer3-mer4-mer5-mer6-mer7-mer8-mer9-mer10-mer11-mer12-mer14-mer16-mer24-mer26-mer32-mer40-mer54-mer60-mer
3,3461,429124277119172811111453511321
Download